Cardiff Oncology, Inc.

Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.

CRDF | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 11055 FLINTKOTE AVENUE, 92121 SAN DIEGO
Website:: https://cardiffoncology.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cardiff Oncology, Inc. is a clinical-stage biotechnology company focused on developing novel therapies for various cancers. The company's approach centers on leveraging the inhibition of Polo-like kinase 1 (PLK1), a well-validated oncology drug target. Its lead asset, onvansertib, is a PLK1 inhibitor being evaluated in clinical programs in combination with standard-of-care (SoC) therapeutics. Cardiff's development strategy is designed to target tumor vulnerabilities, aiming to overcome treatment resistance and deliver superior clinical benefits for patients, particularly in indications with a significant need for new treatment options.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cardiff Oncology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardiff Oncology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Cardiff Oncology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Adtraction Group AB A partner marketing platform driving online sales for brands with a performance-based model.	Sweden	ADTR
Adventure, Inc. A Japanese OTA providing competitive rates for global travel bookings in over 30 languages.	Japan	6030
Adverty AB Adtech platform for seamless, non-intrusive brand advertising in games, AR, and VR.	Sweden	ADVT
Adways Inc. Global mobile marketing firm providing ad tech and agency services, focused on Asian markets.	Japan	2489
AerCap Holdings N.V. Global leader in leasing aircraft, engines, and helicopters to airlines worldwide.	United States of America	AER
Aidma Marketing Communication Corporation Data-driven sales promotions for the retail industry, offering both digital and print solutions.	Japan	9466
AIR LEASE CORP Leases new commercial aircraft to airlines worldwide, offering financing and fleet management.	United States of America	AL
All About,Inc. Japanese digital media group connecting businesses and consumers via e-commerce and product sampling.	Japan	2454
Altimmune, Inc. Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.	United States of America	ALT
AlzeCure Pharma Develops small-molecule drug therapies for Alzheimer's, pain, and cognitive dysfunction.	Sweden	ALZCUR